Is this email not displaying correctly?
View it in your browser.
Newswise - News for Journalists

Newswise Special Wire
Tuesday, May 5, 2015

Public edition | newswise.com

Newswise Cancer Research Wire for 05-May-2015
FacebookTwitterLinkedInStumbleupon

Profiling Approach to Enable Right Lung Cancer Treatment Match

Manchester researchers have tested a new way to genetically profile lung cancer samples, potentially allowing doctors to more easily identify the most appropriate treatment for patients.

 • Image(s) embedded • 

Journal of Thoracic Oncology, May 2015

– University of Manchester

Breast Cancer Vaccines May Work Better with Silicon Microparticles

The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports.

 • Image(s) embedded • 

Cell Reports

– Houston Methodist

Rutgers Cancer Institute of New Jersey is One of Seven Worldwide Sites to Offer Debulking Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer

Rutgers Cancer Institute of New Jersey is one of seven international sites to offer a clinical trial investigating the benefits of a debulking prostatectomy in men newly diagnosed with prostate cancer that has metastasized. The goal is to increase survival rates by potentially improving the effectiveness of other treatments, such as chemotherapy or radiation given after surgery.

 • Image(s) embedded • 

– Rutgers Cancer Institute of New Jersey

Scientists Dramatically Improve Method for Finding Common Genetic Alterations in Tumors

St. Jude Children’s Research Hospital scientists have developed a significantly better computer tool for finding genetic alterations that play an important role in many cancers but were difficult to identify with whole-genome sequencing. The findings appear today in the scientific journal Nature Methods. The tool is an algorithm called CONSERTING, short for Copy Number Segmentation by Regression Tree in Next Generation Sequencing.

 • Image(s) embedded • 

Nature Methods; CA021765

– St. Jude Children's Research Hospital

3D-Printed Trachea among Key Mount Sinai Research Presented at American Association for Thoracic Surgery Meeting

Icahn School of Medicine at Mount Sinai researchers presented several landmark studies at the 2015 American Association for Thoracic Surgery (AATS) meeting in Seattle.

AATS Annual Meeting, April-2015

– Mount Sinai Medical Center

Discovery Could Help Reverse Glucocorticoid Resistance in Some Young Leukemia Patients

Researchers led by St. Jude Children’s Research Hospital scientists have identified a mechanism that helps leukemia cells resist glucocorticoids, a finding that lays the foundation for more effective treatment of cancer and possibly a host of autoimmune diseases. The findings appear online today in the scientific journal Nature Genetics.

 • Image(s) embedded • 

Nature Genetics; CA36401; GM92666; CA141762; CA21765

– St. Jude Children's Research Hospital

Moderate Exercise May Make Cancer Treatments More Effective, Kinesiologist Finds

Kansas State University kinesiology research offers encouraging information for cancer patients: A brisk walk or a slow jog on a regular basis may be the key to improved cancer treatments.

 • Image(s) embedded • 

American Cancer Society

– Kansas State University

Scientists Identify New Drugs to Treat Childhood Eye Cancer

Investigators have discovered a new class of drugs that may more effectively treat retinoblastoma, a cancer of the retina that develops in children. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

(Embargo expired on 03-May-2015 at 09:00 ET)

2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

– Association for Research in Vision and Ophthalmology (ARVO)

Anti-CD47 Treatment Shows Promise in Fight Against Glioblastoma Multiforme

Winner of the Medical Student Summer Research Fellowship Award, Michael Zhang, presented his research, M1 Macrophages Demonstrate a Superior Phagocytic Response Against Glioblastoma Multiforme Following Anti-CD47 Treatment.

(Embargo expired on 03-May-2015 at 13:40 ET)

AANS Annual Meeting, May-2015

– American Association of Neurological Surgeons (AANS)

Surgery for Terminal Cancer Patients Still Common

The number of surgeries performed on terminally ill cancer patients has not dropped in recent years ¬, despite more attention to the importance of less invasive care for these patients to relieve symptoms and improve quality of life.

 • Image(s) embedded • 

Journal of Surgical Research, April 2015

– UC Davis Comprehensive Cancer Center

Moffitt Cancer Center Researchers Discover Link between Inherited Genetic Variations, Outcomes of Non-Small Cell Lung Cancer Patients

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Patients diagnosed with NSCLC have a poor prognosis, with a 5-year survival rate of only 16 percent. Researchers at Moffitt Cancer Center hope to improve NSCLC patient survival with the results of a study that found that inherited genetic variations in interleukin genes are associated with improved patient survival and response to therapy.

Molecular Carcinogenesis

– Moffitt Cancer Center

UNC Researchers Create DNA Repair Map of the Entire Human Genome

When common chemotherapy drugs damage DNA in cancer cells, the cells can’t replicate. But the cells have ways to repair the DNA. The cancer drugs aren’t effective enough. UNC researchers developed a way to find where this DNA repair happens. Their goal is to increase the potency of cancer drugs.

 • Image(s) embedded • 

Genes & Development

– University of North Carolina School of Medicine

Study Finds New Potential Melanoma Drug Target

A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published in the journal Clinical Cancer Research, the authors report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.

 • Image(s) embedded • 

Clinical Cancer Research, May-2015

– University of North Carolina School of Medicine

How to Reset a Diseased Cell

In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in cell communication networks. The manipulation of this communication node, reported in this week’s issue of Proceedings of the National Academy of Sciences, makes it possible to reprogram large parts of a cell’s signaling network instead of targeting only a single receptor or cell signaling pathway.

Proceedings of the National Academy of Sciences

– University of California, San Diego Health Sciences

Patients with Gastrointestinal Tumors at Higher Risk of Other Cancers

Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.

Cancer

– University of California, San Diego Health Sciences

A Protein “Brake” in Metabolic Reprogramming That Restrains Senescent Cells From Becoming Cancerous

In recent years, research has shown that cancerous cells have a different metabolism – essential chemical and nutritional changes needed for supporting the unlimited growth observed in cancer– than normal cells. Now, scientists at The Wistar Institute have identified a way that cells can reprogram their metabolism to overcome a tumor-suppressing mechanism known as senescence, solidifying the notion that altered metabolism is a hallmark of cancer progression.

 • Image(s) embedded •  (Embargo expired on 30-Apr-2015 at 12:00 ET)

Cell Reports, Apr-2015/R01CA160331, P50CA174523, T32CA9171-35, K99CA194309, OC093420, P30ES013508, T32ES019851, CA010815

– Wistar Institute

Pancreatic Cancer Risk Linked to Weak Sunlight

Writing in the April 30 online issue of the Journal of Steroid Biochemistry and Molecular Biology, researchers at University of California San Diego School of Medicine report pancreatic cancer rates are highest in countries with the least amount of sunlight. Low sunlight levels were due to a combination of heavy cloud cover and high latitude.

 • Image(s) embedded •  (Embargo expired on 30-Apr-2015 at 00:05 ET)

Journal of Steroid Biochemistry and Molecular Biology

– University of California, San Diego Health Sciences

Vital Step in Stem Cell Growth Revealed

Salk scientists’ finding could aid regenerative and cancer therapies

 • Video / Image(s) embedded •  (Embargo expired on 30-Apr-2015 at 12:00 ET)

Molecular Cell

– Salk Institute for Biological Studies

Settling an Old Debate

German biologist Theodor Boveri observed early in the last century that cancer cells often harbor multiple copies of a subcellular structure that he had previously named the centrosome. He was also the first to suggest that the extra centrosomes drive cancer. Biologists have since learned a great deal about the structure and many functions of Boveri’s “special organ of cell division.” But why cancer cells harbor multiple copies of this organelle—and whether they are “addicted” to having so many—has remained unanswered. So has the question of whether healthy human cells even require centrosomes to divide. Now, 101 years after Boveri aired his suspicions, a Ludwig Cancer Research paper published in advance online in Science today may have some answers.

(Embargo expired on 30-Apr-2015 at 14:00 ET)

Science

– Ludwig Cancer Research

Trending Stories Report for 30 April 2015

Trending news releases with the most views in a single day. Topics include: new biotech treatment for radiation proctitis, 3D printing in children's health, work and brain health, the importance of medical research, multi-institute collaboration on medical education technology, tax cuts and the economy, cancer survival, and Alzheimer's research.

– Newswise Trends

UV Radiations: NONO Helps to Mend the Damage

Researchers from the lab of Antonio Giordano, MD, PhD, Director and Founder of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA (www.shro.org), have uncovered a new molecular mechanism whereby human cells protect their genome from the detrimental effect of UV radiations.

Oncogene

– Sbarro Health Research Organization (SHRO)

Frequent Aspirin Use Reduces Risk of Cervical Cancer by Nearly Half

Long-term and frequent use of aspirin is associated with significantly decreased risk of cervical cancer, according to a study led by researchers at Roswell Park Cancer Institute (RPCI) and published in the Journal of Lower Genital Tract Disease.

NCI P50CA159981

– Roswell Park Cancer Institute

The Medical Minute: How Artificial Tanning Can Lead to Melanoma

Young women may be up on the latest fashions and trends as they prepare for prom season. But what many don’t know is that the tan that looks oh-so-good with their dress may be the first step toward skin cancer.

– Penn State Milton S. Hershey Medical Center

Large New Study of Phthalates and Breast Cancer Risk

Reliable data are lacking on whether the plasticizing chemicals found in such products as cosmetics, shampoo, flooring and medical tubing, or phthalates, affect human breast cancer risk. A large new study will investigate a possible relationship with a three-year, $1.5 million grant from NIEHS.

 • Image(s) embedded • 

– University of Massachusetts Amherst

Combined Chemotherapy and Immunotherapy Shows Promise for Advanced Prostate Cancers

Researchers at the University of California, San Diego School of Medicine report that blocking or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.

(Embargo expired on 29-Apr-2015 at 13:00 ET)

Nature

– University of California, San Diego Health Sciences

5-Year Survivors of Esophageal Cancer Still Face Low But Constant Risks

According to the American Cancer Society, in 2015 about 17,000 new cases of esophageal cancer will be diagnosed, and about 15,600 people will die from the disease. While the 5-year survival rate in the 1960s and 1970s was only about 5%, improvements in diagnosis, treatment, and management have led to improved survival. However, information is lacking about what happens to long-term survivors of esophageal cancer. A presentation at the AATS Annual Meeting shows that while five-year survival is up to 39%, these patients still face many health risks and should be monitored for 10 years or more.

(Embargo expired on 29-Apr-2015 at 12:10 ET)

95th Annual American Association for Thoracic Surgery Meeting

– American Association for Thoracic Surgery (AATS)

NCI Funding Boosts Breast CT Scanning Research and Development

John M. Boone, a UC Davis medical physicist and professor of radiology, has been awarded a $2.88 million grant from the National Cancer Institute to further develop and research computed tomography (CT) to detect breast cancer.

 • Image(s) embedded • 

– UC Davis Comprehensive Cancer Center

University of Louisville Researchers Detail Role of Silica and Lung Cancer

Researchers at the University of Louisville have detailed a critical connection associated with a major environmental cause of silicosis and a form of lung cancer. Their study is reported in today’s Nature Communications.

 • Image(s) embedded • 

Nature Communications

– University of Louisville

Camptothecin Analog FL118 Can Overcome Treatment Resistance, Outperform Approved Therapies

The latest research from the team that discovered the novel anticancer agent FL118 highlights its distinctive characteristics and provides insights into its ability to overcome treatment resistance.

Molecular Cancer; NCI R21CA180764; NCI P30CA016056

– Roswell Park Cancer Institute

Trending Stories Report for 29 April 2015

Trending news releases with the most views in a single day. Topics include: lung cancer surgery, childhood obesity, physics, imaging, nutrition, civil unrest in Baltimore, Nepal earthquake.

– Newswise Trends

UT Southwestern Scientists Identify Key Receptors Behind Development of Acute Myeloid Leukemia

UT Southwestern Medical Center scientists have discovered that a certain class of receptors that inhibit immune response are crucial for the development of acute myeloid leukemia (AML), the most common acute leukemia affecting adults.

 • Image(s) embedded • 

Nature Cell Biology

– UT Southwestern Medical Center

Pneumonectomy or Lobectomy? Study Shows that Surgeon’s Experience May Be a Contributing Factor for Non-Small Cell Lung Cancer Patients

For patients in the early stage of non-small cell lung cancer, surgical resection yields optimal outcomes. Prior investigations have shown that different resection procedures have very different outcomes, with pneumonectomy associated with three-fold higher mortality than other resection types. While it is understandable that pathological and physiological factors influence a surgeon’s choice of surgery for a particular patient, the results presented in this study suggest that physician discomfort with the operative complexities of a procedure may lead to selection of a technique associated with less favorable outcomes.

(Embargo expired on 28-Apr-2015 at 19:15 ET)

95th Annual American Association for Thoracic Surgery Meeting

– American Association for Thoracic Surgery (AATS)

New Studies Examine the Significant Risk of Life-Threatening Blood Clots in Post-Surgical Lung Cancer Patients

New evidence suggests that lung cancer surgery patients are at higher risk of developing venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), than previously thought, with elevated risks of complications or death. When thromboemboli occur, they may be asymptomatic or attributed to post-surgical pain or complications, and may reflect both the lung cancer itself as well as compromised lung function after surgery. These incidents may also be ascribed to an inconsistent approach to prevention that currently exists among thoracic surgeons and hematologists who care for these patients. Three presentations at the 95th Annual Meeting of the American Association for Thoracic Surgery explore the problem of venous thromboembolism (VTE) after surgery for lung cancer.

(Embargo expired on 28-Apr-2015 at 16:30 ET)

95th Annual American Association for Thoracic Surgery Meeting

– American Association for Thoracic Surgery (AATS)

Trending Stories Report for 28 April 2015

Trending news releases with the most views in a single day. Topics include: Underage drinking, dieting, electrical engineering, neurology and genetics, Nepal earthquake, breast cancer, and supercomputing.

– Newswise Trends

U-Michigan Scientists Observe Deadly Dance Between Nerves and Cancer Cells

In certain types of cancer, nerves and cancer cells enter an often lethal and intricate waltz where cancer cells and nerves move toward one another and eventually engage in such a way that the cancer cells enter the nerves.

Nature Communications

– University of Michigan

Big Data's Bottom Line

In chemotherapy drug handling, hepatitis identification and treatment, and beating back superbugs, nurses crunch the numbers and take the lead.

 • Image(s) embedded • 

– Johns Hopkins School of Nursing

Mayo Clinic-led Research Team Identifies Master Switch for Cancer-Causing HER2 Protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein. However, not all of these patients respond to the drug, and many who do respond eventually acquire resistance.

 • Video embedded • 

Journal of the National Cancer Institute

– Mayo Clinic

Trending Stories Report for 24 April 2015

Trending news releases with the most views in a single day. Topics include: exercise and obesity, Focused Ultrasound to treat uterine fibroids, neurology, diet supplements and cancer (day 4 in top 10), genetics, geology, skin cancer, sleep and Alzheimer's, and water conservation.

– Newswise

Breakthrough Provides New Hope for More Effective Treatments for Patients with HER2 + Breast Cancer

Ahmad M. Khalil, PhD, and his team identified parts of the body that rev up one of the most aggressive forms of breast cancer, HER2+. Their findings appear this month in Breast Cancer Research and Treatment about the 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Breast Cancer Research and Treatment

– Case Western Reserve University

Genetic Sensitivity to Bitter Tastes May Impact Adherence to Oral Smoking Cessation Products

Inspired by a half century’s worth of big tobacco research around the taste of nicotine, a smoking cessation scientist is working to understand how a person’s taste perception might make them a better or worse candidate for oral nicotine replacement therapy.

 • Image(s) embedded • 

Nicotine and Tobacco Research; DA024765 R21; UL1RR025755

– Ohio State University Center for Clinical and Translational Science

Trending Stories Report for 23 April 2015

Trending news releases with the most views in a single day. Topics include: diet supplements and cancer risk (3 days on top 10 list), oral mucositis in cancer treatment, updated breast cancer screening guidelines, climate change, materials science, asthma, mental health and gun violence, genetics and immunology, and multiple sclerosis treatment.

– Newswise Trends

Eligible for Breast Conserving Therapy, Many Still Choose Mastectomy

New research led by Brigham and Women’s Hospital in collaboration with the UNC Lineberger Comprehensive Cancer Center finds that breast-conserving therapy – or the removal of less breast tissue via a lumpectomy – was successful in more than 90 percent of the women who became eligible for this procedure after treatment with chemotherapy. Despite these findings, more than 30 percent who were eligible for breast conserving therapy chose to have the entire breast removed via mastectomy.

 • Image(s) embedded • 

ASA Annual Meeting, April-2015

– University of North Carolina School of Medicine

Hundreds of Cancer Possibilities Arise From Common Skin Mole Mutation

A http:team of international scientists has identified hundreds of possible new genes in mice that could transform benign skin growths into deadly melanomas.

 • Image(s) embedded • 

Nature Genetics

– Houston Methodist

Rutgers Cancer Institute of New Jersey Nurses Design Oncology Nursing Fellowship Program

Responding to tremendous clinical growth at their center and the desire for nursing professionals to be well versed in oncology practice, nurses at Rutgers Cancer Institute of New Jersey developed a specialized Advanced Practice Nursing Fellowship Program to address these needs. The work is being presented as part of a poster presentation at the Oncology Nursing Society’s Annual Congress this week.

 • Image(s) embedded • 

Oncology Nursing Society Annual Congress

– Rutgers Cancer Institute of New Jersey

A Frequent Genomic Alteration Is Identified in a Rare Subset of Breast Cancer

Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic mutations in a gene associated with a rare subset of breast cancer – mutations that cannot otherwise be identified with standard clinical analysis of cells and tissue. The findings, being presented at the AACR Annual Meeting could have therapeutic implications specific to this rare form of the disease, say the authors.

 • Image(s) embedded •  (Embargo expired on 22-Apr-2015 at 08:00 ET)

AACR Annual Meeting 2015

– Rutgers Cancer Institute of New Jersey

Toxic Mushroom-Based Drug May Help Battle Colorectal Cancer

For some time, cancer scientists have considered the toxin, alpha-amanatin derived from “death cap” mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.

 • Image(s) embedded •  (Embargo expired on 22-Apr-2015 at 13:00 ET)

Nature

– University of Texas M. D. Anderson Cancer Center

Botanical Formula Enhances Effects of Tamoxifen Against Breast Cancer

Researchers at the Cancer Research Laboratory, Methodist Research Institute, Indiana University Health found that a botanical formula for breast health inhibited the growth of estrogen receptor-positive (ER+) human breast cancer cells. More importantly, the researchers also found that the formula enhanced the anti-cancer benefits of the drug tamoxifen in the treatment of breast cancer. These results were presented today at the American Association for Cancer Research Annual Meeting 2015.

American Association for Cancer Research Annual Meeting 2015

– Better Health Publishing

Modified Citrus Pectin Enhances Radiation Therapy in Prostate Cancer Treatment

Scientists at Tel Aviv Medical Center, Israel, have found that oral modified citrus pectin (MCP) enhances the anti-cancer and anti-metastatic effects of radiation therapy in the treatment of androgen-independent (AI) aggressive prostate cancer cells. Results were presented today at the American Association for Cancer Research (AACR) Annual Meeting 2015.

American Association for Cancer Research (AACR) Annual Meeting 2015

– Better Health Publishing

Trending Stories Report for 22 April 2015

Trending news releases with the most views in a single day. Topics include: diet supplements and cancer, pancreatic cancer, bird flu, parenting, respiratory health, physics from the DOE office of science, breast cancer awareness, and childhood cancer survivors.

– Newswise Trends

The Association for Molecular Pathology Compiles Current Research on Liquid Biopsy

In general, the article supports the notion that this type of diagnostic testing in and of itself allows for earlier diagnosis, faster and more targeted treatment, reduced costs, and increased quality of life and even increased lifespan for the patient.

The Journal of Molecular Diagnostics, May-2015

– Association for Molecular Pathology

How to Identify Drugs That Work Best for Each Patient

More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best. A new implantable device developed at MIT may change that.

 • Image(s) embedded • 

Science Translational Medicine, Apr-2015

– Koch Institute for Integrative Cancer Research at MIT

Potential New Target to Prevent Breast Cancer Relapse

University of Adelaide researchers have discovered an important factor in the development of breast cancer and its spread, which may present a new target for treatment.

Oncogene

– University of Adelaide

CAP and NSH Release New Guideline to Improve Patient Safety

Today, the College of American Pathologists (CAP) and the National Society for Histotechnology (NSH) released the first evidence-based guideline to ensure patient safety through the uniform labeling of paraffin blocks and slides. The guideline, “Uniform Labeling of Blocks and Slides in Surgical Pathology,” is now available in the online edition of Archives of Pathology & Laboratory Medicine.

– College of American Pathologists (CAP)

Childhood Cancer Survivors More Likely to Claim Social Security Support as Adults

Study shows they're five times more likely to have enrolled in a Social Security disability assistance program.

 • Image(s) embedded • 

– University of Utah Health Sciences

Two New Studies on Honokiol Extract Show Promise for Kidney and Bladder Cancers

The botanical extract honokiol, a biologically active molecule isolated from the bark of Magnolia spp., holds promise as an adjunct treatment for aggressive bladder and kidney cancers, as reported in two new studies. New research on honokiol in bladder cancer was presented at the American Association for Cancer Research (AACR) Annual Meeting 2015. Research on honokiol’s effect on renal cancer metastasis was published in the April 2015 issue of the International Journal of Oncology.

International Journal of Oncology; American Association for Cancer Research (AACR) Annual Meeting 2015

– Better Health Publishing

Mayo Clinic Researchers Identify Methylated DNA Markers That May One Day Lead To Noninvasive Whole Body Cancer Screening

A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers from tumors. The results open the possibility that doctors could one day be able to screen for cancer anywhere in the body with a noninvasive blood test or stool sample. Such tests, if they prove practical and feasible, could mean greater convenience for patients and saved lives through earlier diagnosis of cancer, especially rare and often lethal diseases such as pancreatic cancer or lung cancer.

 • Video embedded • 

AACR Annual Meeting

– Mayo Clinic

Mount Sinai Health System Experts Share Skin Cancer Tips and Patient Stories for Skin Cancer Awareness Month and Melanoma Monday

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives.

Expert(s) available

– Mount Sinai Medical Center

Policy and Public Affairs

Proposed Breast Cancer Screening Guidelines Would Increase Deaths

The breast cancer screening guidelines proposed yesterday by the United States Preventive Services Task Force (USPSTF) would result in thousands of additional and unnecessary breast cancer deaths each year, according to radiologists at Loyola University Health System (LUHS).

– Loyola University Health System

Announcements

Celebrating Survivorship

People who have survived cancer and their loved ones and caregivers will again gather at the University of Louisville for celebration, inspiration and support at the annual Cancer Survivors Celebration. The event is set for 3 p.m., Thursday, April 30, at UofL’s Kosair Charities Clinical and Translational Research building, 505 S. Hancock St. i

 • Image(s) embedded • 

– University of Louisville

New Jersey State Cancer Registry Takes Top Honor

The New Jersey State Cancer Registry (NJSCR), under the direction of Rutgers Cancer Institute of New Jersey and the state Department of Health, has taken first place as one of only three Surveillance, Epidemiology, and End Results (SEER) Program cancer registries in the nation to meet all 14 data quality indicators for excellence.

 • Image(s) embedded • 

– Rutgers Cancer Institute of New Jersey

Psychologist Jonathan Bricker Finalist for 'Geek of the Year Award' by GeekWire

Dr. Jonathan Bricker, a psychologist at Fred Hutchinson Cancer Research Center who studies acceptance and commitment therapy, or ACT, to help people quit smoking and other unhealthy behaviors, has been selected as one of five finalists for GeekWire's prestigious annual “Geek of the Year Award" for using technology to make a positive impact.

 • Image(s) embedded • 

– Fred Hutchinson Cancer Research Center

Marketplace

Markey Launches App for Cancer Clinical Trials

The University of Kentucky Markey Cancer Center recently launched a new iPhone app featuring a searchable database of the open clinical trials at Markey. The app gives Markey patients and their treatment teams an easier way of identifying the clinical trials currently offered that might be beneficial for the patient’s treatment plans.

– University of Kentucky

Expert Pitch

Novel Therapies Are Giving New Hope for Patients with Advanced Melanoma

 • Video embedded • 

– Provectus Biopharmaceuticals, Inc

Understanding Radiation Proctitis: New Approach Addresses the Needs of Ovarian, Colon and Prostate Cancer Patients

 • Video / Image(s) embedded • 

– PlasmaTech Biopharmaceuticals

Ongoing Trial May Lead to Better Understanding of Oral Mucositis, a Debilitating Side Effect Affecting Many Cancer Patients

 • Video embedded • 

– PlasmaTech Biopharmaceuticals

NEWSWISE IS
MOBILE FRIENDLY

CLICK ON ANY STORY IN THE WIRE FROM YOUR MOBILE DEVICE AND SEE FOR YOURSELF!

Tips

Forget your Newswise username/password?
Click "forgot my username/forgot my password" here, or go to our homepage and click "Login" on the top right.

Just a reminder, your password is case sensitive.

Changing your email address(es)? Update your profile by logging in and clicking "My User Profile" at the top right of the page.

Going on vacation? You can hold delivery of your Newswise wire subscriptions by logging in and clicking "My Account" at the top right of the page. Click on the "Subscriptions" tab to enter start and stop dates.

subscribe/unsubscribe :: edit my preferences
© 2015 Newswise, Inc. All Rights Reserved. | 215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417 | Contact Us